The Multiple Sclerosis & Neuroimmunology program involves clinical activities at the RMH MS Centre and basic laboratory activities at the Florey Institute of Neuroscience and Mental Health.
Professor Trevor Kilpatrick and Associate Professor Tomas Kalincik are co-heads of the RMH Multiple Sclerosis (MS) & Neuroimmunology program. Prof Kilpatrick leads the MS Melbourne academic network and A/Prof Kalincik leads the RMH MS Centre. Dr Mark Marriott is head of MS Clinical Trials at the RMH and Dr Katherine Buzzard leads the RMH Neurooncology and Neuroimmunology program, which is run in conjunction with the Peter MacCallum Cancer Centre.
The MS & Neuroimmunology program involves the RMH MS Centre, Florey Institute of Neuroscience and Mental Health and The University of Melbourne. The program collaborates broadly with a number of prominent academic centres nationally and internationally, including the: University of Calgary, Karolinska Institute, Cambridge University, Charles University in Prague, Pitié-Salpêtrière University Hospital, Montreal Neurological Institute-Hospital, Monash Institute of Pharmaceutical Sciences and others.
There are two outpatient clinics, each held once a week at the RMH City Campus:
- The MS & Neuroimmunology clinic is dedicated to the assessment and long-term management of people with a possible or definite diagnosis of MS and other neuroimmunological conditions, including neuromyelitis optica, neurosarcoidosis, autoimmune encephalitis, cerebral vasculitis and myasthenia gravis.
- The MS Clinical Trials clinic provides follow-up and treatment for patients who are participating in clinical trials, with the capacity to accommodate specific trial protocols.
The MS & Neuroimmunology clinic sees approximately 1200 patients with MS and neuroimmunological conditions and is staffed by 8 neurologists with subspecialty training in MS and neuroimmunology. The clinic provides a multidisciplinary approach through a specialist MS nurse, social worker (in collaboration with MS Australia), physiotherapist (in collaboration with RMH Department of Rehabilitation) and neuropsychologist. We collaborate closely with rehabilitation physicians and continence physicians at the RMH Royal Park Campus.
If required, patients with MS and neuroimmunological conditions are admitted to the Neurology ward at the RMH for diagnosis and management under the care of specialist neurologists and with input from the RMH MS Centre staff.
Day Medical Centre
The RMH MS Centre works in close collaboration with the Day Medical Centre at the RMH City Campus. Infusion therapies are administered to patients with MS and neuroimmunological conditions who require these therapies as part of their management. Patients are briefly reviewed by medical staff prior to their infusion of immunotherapy in order to optimise safety of the procedure.
We accept GP and specialist referrals for this service.
Referrals are triaged depending on priority. Emergency cases can present to the Emergency & Trauma Service at any time.
To refer a patient, complete and send your referral to Outpatients by fax to (03) 9342 4234.
You can use the following form or a template from your own system:
Referrals should include:
- relevant clinical history for the patient
- the reason for referral
- patient details including address, date of birth and contact phone numbers
- your details and provider number
- the name of the consultant (for Medicare clinics)
- if your patient requires ongoing management, please identify the referral as being "indefinite"